PeopleBeatingCancer

Active Surveillance in Leukemia: Pros, Cons

Share Button

Active Surveillance in Leukemia: Pros, Cons, and When “Watch and Wait” Makes Sense. You’ve been diagnosed with cancer…but at an early stage and not considered to be aggressive. Do you treat or watch and wait aka practice what is called “active surveillance”?

If you or someone you love has been diagnosed with leukemia, you will probably want to treat your blood cancer immediately. But this post will offer reasons why immediate treatment may not be your best choice.

First and foremost, research has shown that by preparing your body, you can enhance conventional treatments (if you do begin treatment) and reduce or eliminate possible side effects with the complementary therapies below.

Be sure to watch each of the videos about:

I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies is the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage cancer is to combine the best of conventional and evidence-based non-conventional therapies.

I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.

Scroll down the page and post a question or a comment if there’s anything you’d like to know about breast cancer.

Good luck,

David Emerson

Active surveillance of chronic lymphocytic leukemia (CLL)

What Is Active Surveillance in Leukemia?

Active surveillance (also called “watchful waiting”) is a strategy where leukemia is closely monitored without immediate treatment until symptoms or disease progression occur.

  • Most commonly used in chronic lymphocytic leukemia (CLL) and other slow-growing blood cancers
  • Involves regular blood tests, exams, and symptom tracking
  • Treatment begins only when medically necessary

Why Active Surveillance Is Common in Leukemia

Unlike aggressive cancers, many leukemias—especially CLL and indolent lymphomas—can progress slowly over years or even decades.

  • Some patients never require treatment
  • Early treatment often does not improve survival
  • Therapy carries real risks and side effects

👉 Research shows that starting treatment early does NOT improve lifespan in early-stage CLL

👉 Studies also show no harm compared with immediate treatment in asymptomatic patients

The Pros of Active Surveillance in Leukemia

1. Avoids Unnecessary Treatment Toxicity

Cancer therapy—chemotherapy, targeted drugs, immunotherapy—can cause:

  • Fatigue, infections, neuropathy
  • Cardiovascular complications
  • Secondary cancers (rare but real)

By delaying treatment, patients avoid side effects for as long as possible.

👉 This is critical because leukemia therapies are often not curative, but instead used to manage disease over time.

2. No Survival Disadvantage (for Early-Stage Disease)

Multiple studies confirm:

  • Early treatment does not improve overall survival
  • Delayed treatment is equally effective when started at progression

👉 “Watch and wait” is considered a standard of care for early-stage CLL

3. Maintains Quality of Life (Short-Term)

Without treatment:

  • No infusion schedules
  • No drug toxicity
  • Less disruption to daily life

Patients can often live normally for years without therapy.

4. Preserves Future Treatment Options

Delaying therapy may:

  • Prevent early drug resistance
  • Allow access to newer, more effective therapies later

👉 Modern leukemia treatments (e.g., BTK inhibitors, BCL-2 inhibitors) are rapidly evolving

5. Personalized, Risk-Adapted Care

Active surveillance allows clinicians to:

  • Monitor disease biology over time
  • Identify high-risk progression patterns
  • Start treatment at the optimal moment

👉 Real-world data supports risk-adapted treatment timing as safe and effective

The Cons of Active Surveillance in Leukemia

1. Psychological Stress and “Doing Nothing”

One of the biggest downsides:

  • Anxiety about untreated cancer
  • Feeling like you’re “waiting for it to get worse”
  • Pressure from family to start treatment

👉 Studies show higher distress and declining quality of life in some patients under surveillance

2. Uncertainty About Disease Progression

Patients often struggle with:

  • “When will I need treatment?”
  • “Is it getting worse right now?”

👉 Active monitoring can create ongoing uncertainty and emotional burden

3. Potential Decline in Quality of Life Over Time

Surprisingly, some research shows:

  • Quality of life may decline during surveillance
  • Social and emotional well-being may worsen

👉 Compared to treated patients, those under surveillance showed declines in social and functional well-being

4. Risk of Missing Rapid Progression (Rare)

While uncommon:

  • Some leukemias can transform or accelerate
  • Requires careful monitoring and compliance

👉 This is why surveillance includes regular lab work and physician visits

5. Less Visible Support from Others

Because patients aren’t “actively treated”:

  • Friends/family may underestimate the seriousness
  • Emotional support may decrease over time

👉 This can contribute to lower social quality of life

Who Is a Good Candidate for Active Surveillance?

Active surveillance is typically recommended for:

  • Early-stage CLL (Rai stage 0–II)
  • No significant symptoms
  • Stable blood counts
  • No organ compromise (e.g., spleen, lymph nodes)

When Treatment Should Begin

Doctors typically start therapy when:

  • Rapidly rising lymphocyte counts
  • Enlarging lymph nodes or spleen
  • Symptoms (fatigue, night sweats, weight loss)
  • Bone marrow failure (anemia, thrombocytopenia)

Integrative Oncology Perspective

From a PeopleBeatingCancer standpoint, active surveillance is an opportunity—not just a waiting period.

Patients can use this time to:

Evidence-Based Non-Conventional Strategies

  • Anti-inflammatory nutrition (Mediterranean / plant-based diet)
  • Exercise to improve immune function
  • Sleep optimization and circadian rhythm alignment
  • Stress reduction (meditation, CBT, counseling)
  • Targeted supplementation (case-by-case)

👉 Goal: Improve immune surveillance and overall resilience while the disease is stable

Pros and Cons of Active Surveillance in Leukemia

Pros

  • Avoids treatment toxicity
  • No survival disadvantage
  • Maintains normal life (initially)
  • Preserves future treatment options

Cons

  • Anxiety and uncertainty
  • Possible decline in quality of life
  • Requires strict monitoring
  • Risk (rare) of delayed intervention

To learn more about managing your cancer-

Pillar / Core Pages

Supporting Content

Bottom Line

Active surveillance in leukemia is not passive care—it’s strategic care.

For many patients:

  • It avoids unnecessary harm
  • It does not reduce survival
  • It allows time for better therapies to emerge

But it comes with real challenges—especially psychological and emotional ones.

👉 The best approach combines:

  • Careful medical monitoring
  • Personalized risk assessment
  • Integrative strategies to support overall health

Evidence Appendix (Clean Links)

Chronic lymphocytic leukemia (CLL): How to cope during the “watch and wait” period

When you first learn you have cancer, emphasis is typically placed on testing, appointments and developing a treatment plan — and rightly so. But it is also important to prioritize your emotions and the way cancer can impact your mental health.

For people living with chronic lymphocytic leukemia, also called CLL, a diagnosis can come as a major shock. In the early stages of the disease, you may have no symptoms at all. It also may be surprising to learn that until certain symptoms are present or the disease progresses, you may not need treatment right away. This is the “watch and wait” approach, “active surveillance” or “watchful waiting” period of CLL.

Typically, routine checkups are every 3 to 6 months, according to Mazie Tsang, M.D., M.A.S., M.S., a hematologist and CLL expert at Mayo Clinic in Arizona. During these appointments, your healthcare team monitors your cancer by discussing your symptoms, performing a physical exam and running blood tests.

But the interim months between appointments — time when you may be wondering about whether your cancer has progressed — can be emotionally and mentally taxing.

Below, learn about ways to effectively cope with the watch and wait period of CLL.

 

 

Leave a Comment:

Popular posts

Multiple Myeloma Diet
 Multiple Myeloma Multiple Myeloma Diet
Feb 15, 2022
Multiple Myeloma Survivor- A Different kind of Second Opinion-
 Multiple Myeloma
Nov 04, 2022
C-B-D Enhances Velcade (BORT)
 integrative therapy Multiple Myeloma
Aug 07, 2022
Are Endometrial Polyps Overtreated?
 pre-cancer
Nov 14, 2021